Health ❯ Healthcare ❯ Patient Care

Chronic Diseases

Vision Loss Diabetes Management Type 2 Diabetes Heart Disease Obesity Treatment Cancer Treatment Financial Relief Obesity Lung Diseases Management of Multiple Sclerosis

Lilly’s One‑Dose Gene Editor Cuts LDL Cholesterol by Up to 62% in Early Trial

Dose-related PCSK9 and LDL-C reductions came with an early favorable safety readout and leave Lilly poised to begin Phase 2 by year-end.

Roche Files MS Drug Fenebrutinib With Regulators Despite Trial Deaths

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

AstraZeneca’s COPD Antibody Tozorakimab Succeeds in Two Phase 3 Trials

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

Fuji Rebio Seeks Japan Approval for Blood Test to Aid Alzheimer’s Diagnosis

Roche’s Oral BTK Drug Succeeds in Phase 3 MS Trials, Matching Ocrevus in Progressive Disease

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit

Study Finds COPD Patients Report High Burden but Few Detailed Talks With Clinicians

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis

Italian Internal Medicine Wards Face Overcrowding and Staffing Crisis